Home > Publications database > Toward Noninvasive High-Resolution In Vivo pH Mapping in Brain Tumors by 31P-Informed deepCEST MRI. > print |
001 | 301493 | ||
005 | 20250521113230.0 | ||
024 | 7 | _ | |a 10.1002/nbm.70060 |2 doi |
024 | 7 | _ | |a pmid:40374188 |2 pmid |
024 | 7 | _ | |a pmc:PMC12081166 |2 pmc |
024 | 7 | _ | |a 0952-3480 |2 ISSN |
024 | 7 | _ | |a 1099-1492 |2 ISSN |
037 | _ | _ | |a DKFZ-2025-01035 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Schüre, Jan-Rüdiger |0 0000-0002-1472-9471 |b 0 |
245 | _ | _ | |a Toward Noninvasive High-Resolution In Vivo pH Mapping in Brain Tumors by 31P-Informed deepCEST MRI. |
260 | _ | _ | |a New York, NY |c 2025 |b Wiley |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1747743461_3489 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a The intracellular pH (pHi) is critical for understanding various pathologies, including brain tumors. While conventional pHi measurement through 31P-MRS suffers from low spatial resolution and long scan times, 1H-based APT-CEST imaging offers higher resolution with shorter scan times. This study aims to directly predict 31P-pHi maps from CEST data by using a fully connected neuronal network. Fifteen tumor patients were scanned on a 3-T Siemens PRISMA scanner and received 1H-based CEST and T1 measurement, as well as 31P-MRS. A neural network was trained voxel-wise on CEST and T1 data to predict 31P-pHi values, using data from 11 patients for training and 4 for testing. The predicted pHi maps were additionally down-sampled to the original the 31P-pHi resolution, to be able to calculate the RMSE and analyze the correlation, while higher resolved predictions were compared with conventional CEST metrics. The results demonstrated a general correspondence between the predicted deepCEST pHi maps and the measured 31P-pHi in test patients. However, slight discrepancies were also observed, with a RMSE of 0.04 pH units in tumor regions. High-resolution predictions revealed tumor heterogeneity and features not visible in conventional CEST data, suggesting the model captures unique pH information and is not simply a T1 segmentation. The deepCEST pHi neural network enables the APT-CEST hidden pH-sensitivity and offers pHi maps with higher spatial resolution in shorter scan time compared with 31P-MRS. Although this approach is constrained by the limitations of the acquired data, it can be extended with additional CEST features for future studies, thereby offering a promising approach for 3D pH imaging in a clinical environment. |
536 | _ | _ | |a 315 - Bildgebung und Radioonkologie (POF4-315) |0 G:(DE-HGF)POF4-315 |c POF4-315 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a 31P‐MRS |2 Other |
650 | _ | 7 | |a AI |2 Other |
650 | _ | 7 | |a APTw |2 Other |
650 | _ | 7 | |a CEST |2 Other |
650 | _ | 7 | |a brain tumor |2 Other |
650 | _ | 7 | |a deep learning |2 Other |
650 | _ | 7 | |a intracellular pH |2 Other |
650 | _ | 7 | |a pHi |2 Other |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Magnetic Resonance Imaging |2 MeSH |
650 | _ | 2 | |a Hydrogen-Ion Concentration |2 MeSH |
650 | _ | 2 | |a Brain Neoplasms: diagnostic imaging |2 MeSH |
650 | _ | 2 | |a Male |2 MeSH |
650 | _ | 2 | |a Female |2 MeSH |
650 | _ | 2 | |a Middle Aged |2 MeSH |
650 | _ | 2 | |a Adult |2 MeSH |
650 | _ | 2 | |a Neural Networks, Computer |2 MeSH |
700 | 1 | _ | |a Rajput, Junaid |b 1 |
700 | 1 | _ | |a Shrestha, Manoj |b 2 |
700 | 1 | _ | |a Deichmann, Ralf |b 3 |
700 | 1 | _ | |a Hattingen, Elke |b 4 |
700 | 1 | _ | |a Maier, Andreas |b 5 |
700 | 1 | _ | |a Nagel, Armin M |0 P:(DE-He78)054fd7a5195b75b11fbdc5c360276011 |b 6 |u dkfz |
700 | 1 | _ | |a Dörfler, Arnd |b 7 |
700 | 1 | _ | |a Steidl, Eike |0 0000-0001-7464-0236 |b 8 |
700 | 1 | _ | |a Zaiss, Moritz |b 9 |
773 | _ | _ | |a 10.1002/nbm.70060 |g Vol. 38, no. 6, p. e70060 |0 PERI:(DE-600)2002003-X |n 6 |p e70060 |t NMR in biomedicine |v 38 |y 2025 |x 0952-3480 |
909 | C | O | |o oai:inrepo02.dkfz.de:301493 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)054fd7a5195b75b11fbdc5c360276011 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-315 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Bildgebung und Radioonkologie |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2024-12-12 |w ger |
915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2024-12-12 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-12 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-12 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NMR BIOMED : 2022 |d 2024-12-12 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2024-12-12 |
920 | 1 | _ | |0 I:(DE-He78)E020-20160331 |k E020 |l E020 Med. Physik in der Radiologie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)E020-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|